Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Voulgaris (Alexandroupolis, Greece), N. Paxinou (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), T. Mouemin (Alexandroupolis, Greece), K. Chadia (Alexandroupolis, Greece), K. Bonelis (Alexandroupolis, Greece), S. Anevlavis (Alexandroupolis, Greece), M. Froudarakis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece). COPD GOLD classification in patients with COPD-OSA overlap syndrome. 221

Member's Comments

No comment yet.

Related content which might interest you: The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The asthma–COPD overlap syndrome Source: Eur Respir Monogr 2015; 69: 85-95 Year: 2015 Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework Source: Annual Congress 2012 - COPD epidemiology Year: 2012 COPD–bronchiectasis overlap syndrome Source: Eur Respir J 2015; 45: 310-313 Year: 2015 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Prevalence and severity of GOLD defined COPD in adults Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 COPD incidence in OSAS patients (overlap syndrome) and differences between groups Source: Eur Respir J 2005; 26: Suppl. 49, 566s Year: 2005 GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 Alpha1-antytripsin deficiency in portuguese COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013